Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Form 8.5 (EPT/RI)

30 May 2025 10:59

RNS Number : 8143K
Singer Capital Markets Sec Ltd
30 May 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Induction Healthcare Group Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Induction Healthcare Group Plc

(d) Date dealing undertaken:

29 May 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.5P

 

Purchases

 

114,592

 

9.36p

 

9.36p

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

30 May 2025

Contact name:

Cindy Le

Telephone number:

020 7496 3171

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERURVKRVWUVORR
Date   Source Headline
15th Mar 20217:00 amRNSNHS contract wins for Induction Booking
10th Mar 20217:00 amRNS1m UK hospital appointments booked since Oct 2020
8th Mar 20217:00 amRNSNew public sector contracts for Induction Booking
4th Mar 20217:00 amRNSChange of Adviser
19th Jan 20218:00 amRNSDirectorate Change
13th Jan 20217:00 amRNSRFL selects Induction to deliver patient portal
10th Dec 20207:00 amRNSHalf year results
27th Oct 20207:00 amRNSInduction aids rollout of Health Records on iPhone
12th Oct 20207:00 amRNSStrategic Collaboration Between Cerner & Induction
21st Sep 202010:24 amRNSResult of AGM
1st Sep 20207:00 amRNSInduction: Horizon achieves earn-out target
28th Aug 20207:00 amRNSNamed Supplier on NHSX Procurement Framework
6th Aug 202010:00 amRNSAnnual Report and Accounts and Notice of AGM
6th Aug 20207:00 amRNSFull year results for the year ended 31 March 2020
29th Jul 20207:00 amRNSNotice of Results
16th Jul 20201:05 pmRNSHoldings in Company
9th Jun 20205:58 pmRNSHolding(s) in Company
9th Jun 20208:34 amRNSDirector/PDMR Shareholding
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
9th Jun 20208:09 amRNSHolding(s) in Company
5th Jun 20209:57 amRNSResult of General Meeting
20th May 20205:06 pmRNSPublication of Circular
19th May 20207:00 amRNSProposed acquisition of Zesty Limited
16th Apr 20207:00 amRNSMarket Update
2nd Mar 20207:00 amRNSBoard and management changes
28th Nov 20197:00 amRNSHalf-year Results
6th Nov 20197:00 amRNSAcquisition of Horizon Strategic Partners Limited
24th Oct 201910:00 amRNSAppointment of acting Head of Product/Development
17th Oct 20194:57 pmRNSHolding(s) in Company
15th Oct 20193:59 pmRNSHolding(s) in Company
19th Sep 20193:07 pmRNSResult of AGM
30th Aug 201910:18 amRNSAnnual Report and Accounts and Notice of AGM
16th Aug 20197:00 amRNSDirectorate Change
29th Jul 20197:00 amRNSPreliminary Results
19th Jul 20197:00 amRNSBoard appointment
23rd May 201911:10 amRNSHoldings in Company
22nd May 20198:00 amRNSAdmission to trading on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.